Patents Examined by Johnny F. Railey, II
  • CKS method of protein synthesis
    Patent number: 5124255
    Abstract: Disclosed is a method of producing fusion proteins wherein one part of the fusion protein is formed from the bacterial protein CKS.
    Type: Grant
    Filed: November 23, 1988
    Date of Patent: June 23, 1992
    Assignee: Abbott Laboratories
    Inventors: Timothy J. Bolling, Wlodzimierz Mandecki
  • Retrovirus isolated from human lymphoma cell lines
    Patent number: 5108920
    Abstract: A novel retrovirus isolated from human lymphoma cells is disclosed. The retrovirus is characterized by a C-type retroviral particle of approximately 100 nm diameter; and an approximately 27,000 molecular weight p24 core protein. Also disclosed are cell lines from which the virus can be obtained and screening methods for detecting the presence of the virus in human sera.
    Type: Grant
    Filed: June 5, 1989
    Date of Patent: April 28, 1992
    Assignees: Regents of the University of California, Genelabs Incorporated
    Inventors: Valerie L. Ng, Michael S. McGrath, Gregory R. Reyes
  • Isolation, molecular cloning and sequencing of an HIV-1 isolate from a Gabonese donor
    Patent number: 5019510
    Abstract: A new strain of Human Immunodeficiency Virus (HIV), which is the major etiological agent of Acquired Immune Deficiency Syndrome (AIDS), is identified. The new strain, products derived from the new strain, a diagnostic method for detecting antibodies to the strain in biological fluids, and a diagnostic kit for carrying out the method are described.
    Type: Grant
    Filed: October 28, 1987
    Date of Patent: May 28, 1991
    Assignee: Institut Pasteur
    Inventors: Simon Wain-Hobson, Thierry Huet, Eric Delaporte, Francoise Brun-Vezinet
  • Vaccinia DNA
    Patent number: 5017487
    Abstract: New transcriptional regulatory sequences useful in the expression of pro- or eukaryotic proteins in eukaryotic organisms are provided comprising the 5' flanking region of the vaccinia virus late 11 kDa gene. Also described are recombinant vectors and recombinant infectious poxviruses containing such transcriptional regulatory sequences operatively linked to foreign genes, and live vaccines based upon these recombinant infectious poxviruses.
    Type: Grant
    Filed: March 27, 1986
    Date of Patent: May 21, 1991
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Hendrik G. Stunnenberg, Riccardo Wittek